Previous 10 | Next 10 |
LivaNova PLC (LIVN) Q1 2019 Results Earnings Conference Call May 1, 2019, 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice Presiden...
Key findings from study at Leuven University Hospital show no explants due to structural valve deterioration in 11 years of Perceval use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that new clinical data for its sutureless surgical aortic v...
The following slide deck was published by LivaNova PLC in conjunction with their 2019 Q1 earnings Read more ...
LivaNova PLC (NASDAQ: LIVN ): Q1 Non-GAAP EPS of $0.54 misses by $0.04 ; GAAP EPS of -$0.31. More news on: LivaNova PLC, Earnings news and commentary, Healthcare stocks news, Read more ...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2019. For the first quarter of 2019, worldwide sales from continuing operations were $250.8 million, an increase of 0.2 percent on a reporte...
Gainers: Vital Therapies (NASDAQ: VTL ) +199% . JMU Limited (NASDAQ: JMU ) +24% . Aehr Test Systems (NASDAQ: AEHR ) +22% . GEE Group (NYSEMKT: JOB ) +19% . ChinaNet Online Holdings (NASDAQ: CNET ) +15% . RumbleON (NASDAQ: RMBL ) +15% . Hancock Jaffe Laboratories (NASDAQ: HJLI )...
LivaNova ( LIVN -28% ) slumps on almost double normal volume in early trade following its release of preliminary Q1 results that showed no yoy growth due to unexpected weakness in the U.S. More news on: LivaNova PLC, Healthcare stocks news, Stocks on the move, Earnings news and comment...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced preliminary unaudited revenue results for the quarter ended March 31, 2019. Preliminary First Quarter 2019 Results The Company expects worldwide sales from continuing operations for the first...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Thad Huston, Chief Financial Officer of LivaNova, will present at the Needham Healthcare Conference on Tuesday, April 9 in New York at 2:10 p.m. Eastern Daylight Time. The discussion will be availabl...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced an agreement to settle approximately 75 percent of the previously disclosed litigation in the U.S. related to the Company’s 3T Heater-Cooler device. Under the terms of the agreement and subjec...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...